Addressing Prostate Cancer Information Disparities With eHealth Technology
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 125
- 试验地点
- 3
- 主要终点
- Prostate cancer screening knowledge
研究概览
简要总结
This is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that will empower them to take part in decision-making regarding prostate cancer screening (PCS). The Prostate Cancer Screening Preparation (PCSPrep) tool was designed with intend to be delivered in primary care settings with attention to patient/provider interaction. Funding for this study comes from the National Institute of Health/National Cancer Institute (1R21CA178296).
详细描述
STUDY AIMS AIM 1: Among AA men ages 45-70, estimate the impact of PCSPrep on primary outcomes: (a) knowledge; (b) confidence in ability to make informed decisions and communicate with provider; (c) consistency between values & PCS preferences.
AIM 2: Among primary care providers, to assess secondary outcomes: (a) perceptions regarding patient engagement in SDM; and (b) concordance with patient's ratings of SDM.
AIM 3: Among patients, providers and clinic staff, document the feasibility and acceptability of integrating PCSPrep into primary care practices.
RECRUITMENT & ENROLLMENT
Primary Care Providers Recruitment:
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 45 Years 至 70 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •African american men,
- •ages 45-70 who are able to provide informed consent to participate in the educational intervention and associated data collection activities.
- •English speaking
排除标准
- •no prior personal history of prostate cancer
- •no prior prostate cancer screening with the prostate specific antigen test within preceding three years
- •inability to speak English
结局指标
主要结局
Prostate cancer screening knowledge
时间窗: Baseline (T0) upon enrollment into study; immediately following use of decision aid (PCSPrep) approximately 30 minutes after baseline (T1)
Knowledge regarding the potential benefits, harms and limitations of prostate cancer screening
Decision self-efficacy
时间窗: Baseline (T0) upon enrollment into study; immediately following use of decision aid (PCSPrep) approx 30 min after baseline (T1); approximately one hour later, after visiting with primary care provider (T3)
Confidence in ones ability to gather requisite information and to make an informed decision
Decisional consistency
时间窗: Baseline (T0) upon enrollment into study; immediately following use of decision aid (PCSPrep) approx 30 min after baseline (T1); approximately one hour later, after visiting with primary care provider (T3)
Consistency between decision about screening and stated values regarding the pros and cons of screening
次要结局
未报告次要终点
研究者
Jennifer Allen
Associate Professor
Tufts University